Navigating the Nuclear Medicine Frontier: Logistical Hurdles and Regulatory Landscapes
The operational reality of nuclear medicine is dictated by the physics of instability. Unlike conventional pharmacotherapy, where inventory management relies on stable chemical shelf-lives, radiopharmaceuticals are defined by time-sensitive isotopes that undergo continuous physical transformation. As a result, the clinical supply chain is not merely a delivery system but a kinetic race against isotopic decay. For industry stakeholders, success requires a sophisticated synthesis of rapid logistics, stringent regulatory navigation, and clinical innovation.